A PmrB-regulated deacetylase required for lipid A modification and polymyxin resistance in Acinetobacter baumannii

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 12, 2015, Pages 7911-7914

  Chin, Chui Yoke ^a   Gregg, Kelsey A ^b   Napier, Brooke A ^a,c   Ernst, Robert K ^b   Weiss, David S ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; LIPID A; NAXD DEACETYLASE; PHOSPHOTRANSFERASE; POLYMYXIN; SENSOR KINASE PMRB; UNCLASSIFIED DRUG; ACETYLGALACTOSAMINE DEACETYLASE; AMIDASE; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; PMRB PROTEIN, BACTERIA; POLYMYXIN B; TRANSCRIPTION FACTOR;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; DELETION MUTANT; GENE CONTROL; NONHUMAN; PRIORITY JOURNAL; ACINETOBACTER INFECTION; CHEMICAL STRUCTURE; DRUG EFFECTS; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; AMIDOHYDROLASES; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; DRUG RESISTANCE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; LIPID A; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; POLYMYXIN B; TRANSCRIPTION FACTORS;

EID: 84954544161     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00515-15     Document Type: Article

References (16)

1. Centers for Disease Control and Prevention. 2013. Antibiotic resistance threats in the United States. Centers for Disease Control and Prevention, Atlanta, GA.
2. Falagas ME, Rafailidis PI, Matthaiou DK. 2010. Resistance to polymyxins: mechanisms, frequency and treatment options. Drug Resist Updat 13:132-138. http://dx.doi.org/10.1016/j.drup.2010.05.002.
3. Vaara M. 2010. Polymyxins and their novel derivatives. Curr Opin Microbiol 13:574-581. http://dx.doi.org/10.1016/j.mib.2010.09.002.
4. Olaitan AO, Morand S, Rolain JM. 2014. Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria. Front Microbiol 5:643. http://dx.doi.org/10.3389/fmicb.2014.00643.
5. Cai Y, Chai D, Wang R, Liang B, Bai N. 2012. Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies. J Antimicrob Chemother 67:1607-1615. http://dx.doi.org/10.1093/jac/dks084.
6. Neonakis IK, Samonis G, Messaritakis H, Baritaki S, Georgiladakis A, Maraki S, Spandidos DA. 2010. Resistance status and evolution trends of Klebsiella pneumoniae isolates in a university hospital in Greece: ineffectiveness of carbapenems and increasing resistance to colistin. Chemotherapy 56:448-452. http://dx.doi.org/10.1159/000320943.
7. Gunn JS. 2008. The Salmonella PmrAB regulon: lipopolysaccharide modifications, antimicrobial peptide resistance and more. Trends Microbiol 16:284-290. http://dx.doi.org/10.1016/j.tim.2008.03.007.
8. Adams MD, Nickel GC, Bajaksouzian S, Lavender H, Murthy AR, Jacobs MR, Bonomo RA. 2009. Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system. Antimicrob Agents Chemother 53:3628-3634. http://dx.doi.org/10.1128/AAC.00284-09.
9. Beceiro A, Llobet E, Aranda J, Bengoechea JA, Doumith M, Hornsey M, Dhanji H, Chart H, Bou G, Livermore DM, Woodford N. 2011. Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system. Antimicrob Agents Chemother 55:3370-3379. http://dx.doi.org/10.1128/AAC.00079-11.
10. Arroyo LA, Herrera CM, Fernandez L, Hankins JV, Trent MS, Hancock RE. 2011. The pmrCAB operon mediates polymyxin resistance in Acinetobacter baumannii ATCC 17978 and clinical isolates through phosphoethanolamine modification of lipid A. Antimicrob Agents Chemother 55: 3743-3751. http://dx.doi.org/10.1128/AAC.00256-11.
11. Pelletier MR, Casella LG, Jones JW, Adams MD, Zurawski DV, Hazlett KR, Doi Y, Ernst RK. 2013. Unique structural modifications are present in the lipopolysaccharide from colistin-resistant strains of Acinetobacter baumannii. Antimicrob Agents Chemother 57:4831-4840. http://dx.doi.org/10.1128/AAC.00865-13.
12. Llewellyn AC, Zhao J, Song F, Parvathareddy J, Xu Q, Napier BA, Laroui H, Merlin D, Bina JE, Cotter PA, Miller MA, Raetz CR, Weiss DS. 2012. NaxD is a deacetylase required for lipid A modification and Francisella pathogenesis. Mol Microbiol 86:611-627. http://dx.doi.org/10.1111/mmi.12004.
13. Tamayo R, Ryan SS, McCoy AJ, Gunn JS. 2002. Identification and genetic characterization of PmrA-regulated genes and genes involved in polymyxin B resistance in Salmonella enterica serovar typhimurium. Infect Immun 70:6770-6778. http://dx.doi.org/10.1128/IAI.70.12.6770-6778.2002.
14. Aguirre A, Lejona S, Vescovi EG, Soncini FC. 2000. Phosphorylated PmrA interacts with the promoter region of ugd in Salmonella enterica serovar typhimurium. J Bacteriol 182:3874-3876. http://dx.doi.org/10.1128/JB.182.13.3874-3876.2000.
15. Marchal K, De Keersmaecker S, Monsieurs P, van Boxel N, Lemmens K, Thijs G, Vanderleyden J, De Moor B. 2004. In silico identification and experimental validation of PmrAB targets in Salmonella typhimurium by regulatory motif detection. Genome Biol 5:R9. http://dx.doi.org/10.1186 /gb-2004-5-2-r9.
16. McPhee JB, Lewenza S, Hancock RE. 2003. Cationic antimicrobial peptides activate a two-component regulatory system, PmrA-PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa. Mol Microbiol 50:205-217. http://dx.doi.org/10.1046/j.1365-2958.2003.03673.x.